Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
ICCC

Overview Financials Analysis

ImmuCell Corporation

ICCC · NASDAQ

Analyze with AI

Filings0

Total reported value$0.0

Manager	Shares	Value	Change

No activity matches your filters yet.

Previous
Next

SymbolICCC

Market Cap$55.6M

IPO Date1987-05-05

CEOMichael F. Brigham

Employees69

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ Capital Market

Intelligent Bio Solutions Inc.

INBS · NASDAQ

$9.53

+132.44%

Anghami Inc.

ANGH · NASDAQ

$3.77

+62.50%

UTime Limited

WTO · NASDAQ

$1.02

+61.09%

Thunder Power Holdings, Inc.

AIEV · NASDAQ

$0.261

+58.18%

Inflection Point Acquisition Corp. V

IPEXR · NASDAQ

$0.80

+52.00%

Peers

Coeptis Therapeutics, Inc.

COEP · NASDAQ

$14.25

-3.06%

Cue Biopharma, Inc.

CUE · NASDAQ

$0.3054

+0.99%

Equillium, Inc.

EQ · NASDAQ

$1.55

+0.00%

Fortress Biotech, Inc.

FBIO · NASDAQ

$3.66

+2.23%

Genenta Science S.p.A.

GNTA · NASDAQ

$1.49

+4.93%

Century Therapeutics, Inc.

IPSC · NASDAQ

$0.9948

-0.42%

NRx Pharmaceuticals, Inc.

NRXP · NASDAQ

$2.71

+3.04%

OS Therapies Incorporated

OSTX · NYSE

$1.40

-5.41%

Outlook Therapeutics, Inc.

OTLK · NASDAQ

$1.58

-15.51%

Senti Biosciences, Inc.

SNTI · NASDAQ

$1.04

-0.95%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.